Ambev (NYSE:ABEV) Stock Rating Lowered by Wall Street Zen

Ambev (NYSE:ABEV) was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued on Saturday.

ABEV has been the subject of several other reports. Sanford C. Bernstein restated a “market perform” rating and set a $2.88 price target on shares of Ambev in a report on Wednesday, November 26th. Barclays lifted their target price on shares of Ambev from $2.50 to $3.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 17th. Finally, Weiss Ratings raised shares of Ambev from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, March 5th. One equities research analyst has rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Ambev currently has an average rating of “Hold” and a consensus target price of $2.69.

Ambev Stock Down 0.2%

ABEV stock opened at $2.87 on Friday. The company has a market cap of $45.15 billion, a PE ratio of 15.92, a price-to-earnings-growth ratio of 2.11 and a beta of 0.64. The company has a quick ratio of 0.73, a current ratio of 0.96 and a debt-to-equity ratio of 0.03. Ambev has a 52 week low of $2.10 and a 52 week high of $3.24. The business has a 50-day simple moving average of $2.87 and a 200 day simple moving average of $2.53.

Ambev (NYSE:ABEV) last posted its quarterly earnings results on Thursday, February 12th. The company reported $0.05 EPS for the quarter, hitting analysts’ consensus estimates of $0.05. The company had revenue of $4.50 billion during the quarter, compared to analysts’ expectations of $4.28 billion. Ambev had a return on equity of 16.41% and a net margin of 17.75%. Sell-side analysts anticipate that Ambev will post 0.18 EPS for the current fiscal year.

Institutional Trading of Ambev

Hedge funds have recently bought and sold shares of the business. Larry Mathis Financial Planning LLC bought a new position in Ambev in the 4th quarter valued at about $193,000. Advisortrust Partners LLC bought a new stake in Ambev during the 4th quarter worth approximately $43,000. Corient Private Wealth LLC raised its stake in shares of Ambev by 0.9% in the fourth quarter. Corient Private Wealth LLC now owns 2,850,615 shares of the company’s stock worth $7,041,000 after purchasing an additional 25,239 shares during the last quarter. Hsbc Holdings PLC raised its stake in shares of Ambev by 7.5% in the fourth quarter. Hsbc Holdings PLC now owns 2,488,702 shares of the company’s stock worth $6,147,000 after purchasing an additional 174,599 shares during the last quarter. Finally, S Harris Financial Group LLC bought a new position in shares of Ambev in the fourth quarter valued at approximately $28,000. Institutional investors and hedge funds own 8.13% of the company’s stock.

About Ambev

Ambev (NYSE: ABEV) is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company’s core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.

The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.